Brianna Aravich
idstudentba.bsky.social
Brianna Aravich
@idstudentba.bsky.social
Emerging Risk of Campylobacter spp. Infection Associated with Anti-BCMA and Anti-GPRC5D Bispecific Antibodies

✅ Just Accepted
🔗 https://bit.ly/3LsCGeP
November 10, 2025 at 2:54 PM
Risk factors for Lyme disease in the general population - a survey of adults and caregivers in 28 states

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hCops2
November 3, 2025 at 2:10 PM
Epstein-Barr Virus Antibody Response Patterns in Endemic and Non-Endemic Cases of Nasopharyngeal Carcinoma

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IXcI2a
October 20, 2025 at 2:41 PM
Metagenomic Sequencing of Blood Culture Broth for Diagnosing Fastidious Endocarditis

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4qbRJcA
October 20, 2025 at 2:41 PM
Exploring the interaction between injection site and biological sex on the real-world population pharmacokinetics of long acting cabotegravir and rilpirivine in people living with HIV

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4obm2ya
October 14, 2025 at 1:42 AM
October 14, 2025 at 1:41 AM
Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4o1oLdK
October 6, 2025 at 2:32 PM
Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4pxWnBd
September 29, 2025 at 7:02 PM
Case management of enteric fever is challenging due to clinical presentation overlaps, unreliable diagnostic tests, & widespread AMR.

A recent Seminar explores the evidence supporting effective case management of patients with suspected enteric fever: tinyurl.com/32rvncvn
September 22, 2025 at 2:00 PM
In a randomized, controlled trial, persons with early syphilis received a single treatment or three treatments with benzathine penicillin G at a dose of 2.4 million units. No benefit was seen with the additional doses. Full trial results and Research Summary: nej.md/3UVCKVZ

#MedSky #IDSky
September 16, 2025 at 2:56 PM
The Role of Enoxaparin in Influenza Virus Infections and Its Therapeutic Implications

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4guIxf6
September 16, 2025 at 2:53 PM
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

#IDSky
September 8, 2025 at 6:43 PM
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections

✅ Just Accepted
https://bit.ly/426MyQH
September 8, 2025 at 6:43 PM
A new oral option for gonorrhea?

In the Eagle-1 Phase 3 trial, gepotidacin achieved noninferior cure rates (>90%) compared to ceftriaxone and azithromycin for uncomplicated urogenital gonorrhea.

What would you want to see before considering an oral agent like this in clinical practice?
April 21, 2025 at 6:22 PM